Remembering Thomas E. Kurtz

By MIKE MAGEE This has been a challenging week for me, but not for the reasons you might think. Compartmentalization skills have allowed me to push the 2024 Presidential election into the back reaches of my mind as I worked to complete teaching a course on “AI and Medicine” at the Presidents College at the…

Read More

The ICHRA Moment Is Here — Are You Ready for It?

ICHRA is surging in popularity as an option for employer-sponsored insurance to access the individual market, as employers rethink traditional group plans with unpredictable renewal rates and employees seek personalized healthcare. Here’s a closer look at why investors and politicians are eyeing ICHRA. The post The ICHRA Moment Is Here — Are You Ready for It?…

Read More

Classifying Misoprostol and Mifepristone as Controlled Substances: Implications for the Management of Non-Abortion Related Conditions

This data note analyzes employer-sponsored insurance and Medicaid claims data to see how mifepristone and misoprostol—two drugs used in the medication abortion regimen—are prescribed for reasons other than abortion including management of miscarriages, abnormal bleeding or hemorrhage, as well as IUD insertions and other conditions.

Read More

Daron Acemoglu, Simon Johnson and James Robinson win 2024 Nobel Prize in Economics

The Nobel Prize committee summarizes their contributions as follows: Some countries become trapped in a situation with extractive institutions and low economic growth. The introduction of inclusive institutions would create long-term benefits for everyone, but extractive institutions provide short-term gains for the people in power. As long as the political system guarantees they will remain…

Read More